Harvard Bioscience (HBIO) Interest Coverage Ratio (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly Interest Coverage Ratio came in at 0.82 in Q1 2026, up 98.45% year-on-year from 0.41 in Q1 2025, and down 156.12% on a QoQ basis from 1.46 in Q4 2025.
Harvard Bioscience (HBIO) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has 17 years of Interest Coverage Ratio data on file, last reported at 0.82 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 98.45% year-over-year to 0.82 in Q1 2026; TTM through Mar 2026 was 0.06, a 99.89% increase from a year earlier, with the FY2025 full-year figure at 2.44, down 599.35% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.82, down from 1.46 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for HBIO reached as high as 1.69 in Q2 2022 and fell as low as 52.89 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 3.44 across 5 years, with a median of 0.46 in 2025.
- Across the five-year window, Interest Coverage Ratio plunged 4967.63% in 2022 and surged 20964.69% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.78 in 2022, then jumped by 80.96% to 0.15 in 2023, then soared by 95.26% to 0.01 in 2024, then surged by 20964.69% to 1.46 in 2025, then tumbled by 156.12% to 0.82 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.82 in Q1 2026, 1.46 in Q4 2025, and 0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -51.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.40 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 0.62 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 0.60 |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 76.51 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 1.33 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -0.19 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 0.39 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.52 |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | 1.46 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -52.89 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | -1.27 |
| Jun 30, 2024 | -1.17 |
| Mar 31, 2024 | -2.09 |
| Dec 31, 2023 | -0.15 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 1.30 |
| Dec 31, 2022 | -0.78 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | 1.69 |
| Mar 31, 2022 | -2.83 |
| Dec 31, 2021 | -2.15 |
| Sep 30, 2021 | 0.04 |
| Jun 30, 2021 | 0.01 |